ArticleNature reviews. Drug discovery2023
eTRANSAFE: data science to empower translational safety assessment.
Article in Nature reviews. Drug discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Lentiviral-mediated expression of cytochrome P450 2D6 in HepaRG cells: new means for in vitro xenobiotic biotransformation and cellular response to chimeric viral mRNA.Archives of toxicology · 2026Article
- What's new in digital and computational pathology 2026: advances in adoption, standards, AI technologies, and clinical integration.Journal of pathology and translational medicine · 2026Article
- Analysis of rat toxicology studies: statistical agreement between virtual and concurrent controls in detecting treatment effects on liver enzymes.Frontiers in pharmacology · 2026Article
- A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary Data.Journal of chemical information and modeling · 2025Article
- Mapping between clinical and preclinical terminologies: eTRANSAFE's Rosetta stone approach.Journal of biomedical semantics · 2025Article
- PretoxTM: a text mining system for extracting treatment-related findings from preclinical toxicology reports.Journal of cheminformatics · 2025Article
- Review
- The Innovative Health Initiative public-private partnership: a catalyst for big data-driven health research and innovation.Frontiers in medicine · 2025Article
- Retrospective analysis of clinical laboratory parameters in Han Wistar rat controls.Frontiers in toxicology · 2025Article
- Cross study analyses of SEND data: toxicity profile classification.Toxicological sciences : an official journal of the Society of Toxicology · 2024Article
- AI-driven Discovery of Morphomolecular Signatures in Toxicology.bioRxiv : the preprint server for biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
61 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
37316648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.